Business Standard

Dr Reddy's launches Doxycycline Capsules in the US

Image

Dr. Reddy's Laboratories announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).

Dr. Reddy's Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 03 2024 | 3:50 PM IST

Explore News